Results 241 to 250 of about 4,747,249 (340)

Fabrication of magnetic porous hollow silica drug carriers using CaCO3∕Fe3O4 composite nanoparticles and cationic surfactant double templates [PDF]

, 2008
Hui Ma, Jisheng Zhou, Daniela Caruntu, Ming Yu, J. F. Chen, C.J. O’Connor, Weilie Zhou   +6 more
openalex   +1 more source

Screening for Social Determinants of Health in Patients With Systemic Lupus Erythematosus: A Point‐of‐Care Feasibility Study

Arthritis Care &Research, EarlyView.
Objective Social determinants of health (SDoH) can impact outcomes but are not routinely screened for in US outpatient rheumatology clinics. This study determined the feasibility of routine point‐of‐care SDoH screening among patients with systemic lupus erythematosus (SLE) and associated barriers and facilitators at the physician, care team, and ...
S. Sam Lim, Vijay R. Nadipelli, Michelle Bruno, Daphne Lew, Bernard Rubin, Charmayne M. Dunlop‐Thomas, Kelsey Hulcher, Kristi R. Mitchell, Lydia Demetriou, Jeff Berko, Jason Bao, Alfred H. J. Kim   +11 more
wiley   +1 more source

Recent Advances in the Use of Cubosomes as Drug Carriers with Special Emphasis on Topical Applications. [PDF]

J Lipids
Nath AG, Dubey P, Kumar A, Vaiphei KK, Rosenholm JM, Bansal KK, Gulbake A.   +6 more
europepmc   +1 more source

Chitosan and lactic acid-grafted chitosan nanoparticles as carriers for prolonged drug delivery

, 2006
Narayan Bhattarai, Hassna R. Ramay, Shinn‐Huey S. Chou, Miqin Zhang   +3 more
openalex   +1 more source

Selective targeting by preS1 domain of hepatitis B surface antigen conjugated with phosphorylcholine‐based amphiphilic block copolymer micelles as a biocompatible, drug delivery carrier for treatment of human hepatocellular carcinoma with paclitaxel [PDF]

, 2008
Ryohei Miyata, Masakazu Ueda, Hiromitsu Jinno, Tomohiro Konno, Kazuhíko Ishihara, Nobutoshi Ando, Yuko Kitagawa   +6 more
openalex   +1 more source

Treating lupus nephritis patients to lupus low disease activity reduces renal relapse and preserves long‐term kidney function

Arthritis Care &Research, Accepted Article.
Objective Lupus low disease activity state (LLDAS) is a validated treatment target in systemic lupus erythematosus (SLE) but limited studies have explored the role of LLDAS in lupus nephritis (LN). This study aims to investigate the frequency and predictors of LLDAS attainment, and its benefit on LN relapse and renal function preservation in patients ...
Chak Kwan Cheung, Desmond YH Yap, KL Lee, Philip H Li, Iris YK Tang, Chak Sing Lau, Shirley CW Chan   +6 more
wiley   +1 more source

Hybrid Nanoparticles Based on Mesoporous Silica and Functionalized Biopolymers as Drug Carriers for Chemotherapeutic Agents. [PDF]

Materials (Basel)
Curcio F, Sanguedolce M, Filice L, Testa F, Catapano G, Giordano F, Trombino S, Cassano R.   +7 more
europepmc   +1 more source

Enhancement of Anticancer Activity in Antineovascular Therapy Is Based on the Intratumoral Distribution of the Active Targeting Carrier for Anticancer Drugs

, 2006
Noriyuki Maeda, Souichiro Miyazawa, Kosuke Shimizu, Tomohiro Asai, Sei Yonezawa, Sadaya Kitazawa, Yukihiro Namba, Hideo Tsukada, Naoto Oku   +8 more
openalex   +2 more sources

Global and regional temporal changes in cross‐country inequalities of site‐specific osteoarthritis burden, 1990–2021

Arthritis Care &Research, Accepted Article.
Objective This study examined the global and regional temporal changes in cross‐country inequalities of site‐specific osteoarthritis (OA) burden from 1990 to 2021. Methods Age‐standardized years lived with disability rate for site‐specific OA across 204 countries/territories were obtained from the Global Burden of Diseases Study (GBD) 2021.
Haowei Chen, Lei Si, David J Hunter, Lei Zhang, Zhe‐Sheng Chen, Xiaomeng Wang, Vicky Duong, Zhounan Zhou, Peihua Cao, Han Cen, Su'an Tang, Tianyu Chen, Houjun Xue, Zhaohua Zhu, Changhai Ding   +14 more
wiley   +1 more source

Endosomal escape mechanisms of extracellular vesicle-based drug carriers: lessons for lipid nanoparticle design. [PDF]

Extracell Vesicles Circ Nucl Acids
Hagedorn L, Jürgens DC, Merkel OM, Winkeljann B.   +3 more
europepmc   +1 more source